News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
213,440 Results
Type
Article (14430)
Company Profile (20)
Press Release (198990)
Section
Business (73142)
Career Advice (234)
Deals (11964)
Drug Delivery (30)
Drug Development (28841)
Employer Resources (22)
FDA (5061)
Job Trends (4834)
News (118420)
Policy (9220)
Tag
Academia (515)
Adcomms (1)
Allergies (28)
Alliances (12229)
ALS (34)
Alzheimer's disease (298)
Antibody-drug conjugate (ADC) (28)
Approvals (5101)
Artificial intelligence (43)
Autoimmune disease (3)
Automation (2)
Bankruptcy (101)
Best Places to Work (3565)
BIOSECURE Act (1)
Biosimilars (26)
Biotechnology (17)
Bladder cancer (26)
Brain cancer (14)
Breast cancer (94)
Cancer (717)
Cardiovascular disease (53)
Career advice (217)
Career pathing (2)
CAR-T (26)
Cell therapy (82)
Cervical cancer (12)
Clinical research (24694)
Collaboration (157)
Compensation (126)
Complete response letters (1)
COVID-19 (675)
CRISPR (13)
C-suite (28)
Cystic fibrosis (19)
Data (869)
Denatured (3)
Depression (18)
Diabetes (94)
Diagnostics (1659)
Digital health (4)
Diversity, equity & inclusion (2)
Drug discovery (23)
Drug pricing (11)
Drug shortages (11)
Duchenne muscular dystrophy (21)
Earnings (46661)
Editorial (13)
Employer branding (4)
Employer resources (17)
Events (28766)
Executive appointments (80)
FDA (5476)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (138)
Gene editing (25)
Generative AI (4)
Gene therapy (67)
GLP-1 (243)
Government (986)
Grass and pollen (2)
Guidances (119)
Healthcare (4671)
Huntington's disease (5)
IgA nephropathy (2)
Immunology and inflammation (29)
Indications (8)
Infectious disease (723)
Inflammatory bowel disease (35)
Influenza (14)
Intellectual property (18)
Interviews (24)
IPO (6530)
IRA (5)
Job creations (1489)
Job search strategy (206)
Kidney cancer (5)
Labor market (8)
Layoffs (143)
Leadership (1)
Legal (1955)
Liver cancer (22)
Lung cancer (131)
Lymphoma (72)
Machine learning (2)
Management (8)
Manufacturing (81)
MASH (24)
Medical device (3386)
Medtech (3386)
Mergers & acquisitions (5555)
Metabolic disorders (232)
Multiple sclerosis (23)
NASH (4)
Neurodegenerative disease (13)
Neuropsychiatric disorders (5)
Neuroscience (439)
NextGen: Class of 2025 (1580)
Non-profit (946)
Now hiring (4)
Obesity (128)
Opinion (30)
Ovarian cancer (21)
Pain (20)
Pancreatic cancer (28)
Parkinson's disease (36)
Partnered (5)
Patents (51)
Patient recruitment (18)
Peanut (16)
People (12331)
Pharmaceutical (4)
Pharmacy benefit managers (1)
Phase I (6634)
Phase II (10624)
Phase III (9299)
Pipeline (793)
Policy (10)
Postmarket research (1026)
Preclinical (2295)
Press Release (11)
Prostate cancer (29)
Psychedelics (5)
Radiopharmaceuticals (49)
Rare diseases (93)
Real estate (1876)
Recruiting (11)
Regulatory (6792)
Reports (17)
Research institute (444)
Resumes & cover letters (16)
Rett syndrome (1)
RSV (17)
Schizophrenia (15)
Series A (23)
Series B (14)
Sickle cell disease (17)
Special edition (4)
Spinal muscular atrophy (53)
Sponsored (3)
Startups (960)
Stomach cancer (3)
Supply chain (15)
Tariffs (9)
The Weekly (3)
Vaccines (216)
Venture capitalists (9)
Weight loss (92)
Women's health (6)
Worklife (1)
Date
Today (107)
Last 7 days (378)
Last 30 days (952)
Last 365 days (9449)
2025 (3303)
2024 (10254)
2023 (11680)
2022 (13452)
2021 (15115)
2020 (13857)
2019 (10880)
2018 (7918)
2017 (28298)
2016 (35796)
2015 (8604)
2014 (5802)
2013 (3927)
2012 (4692)
2011 (5110)
2010 (4818)
Location
Africa (240)
Alabama (8)
Arizona (49)
Asia (14280)
Australia (2218)
California (1669)
Canada (630)
China (182)
Colorado (80)
Connecticut (73)
Delaware (63)
Europe (32913)
Florida (252)
Georgia (62)
Idaho (7)
Illinois (159)
India (7)
Indiana (104)
Japan (59)
Kansas (28)
Kentucky (4)
Louisiana (5)
Maine (24)
Maryland (230)
Massachusetts (1282)
Michigan (43)
Minnesota (93)
Missouri (18)
Montana (7)
Nevada (22)
New Hampshire (16)
New Jersey (576)
New Mexico (4)
New York (500)
North Carolina (270)
Northern California (825)
Ohio (26)
Oklahoma (1)
Oregon (7)
Pennsylvania (360)
Puerto Rico (8)
Rhode Island (4)
South America (381)
South Carolina (1)
Southern California (604)
Tennessee (15)
Texas (242)
United States (6435)
Utah (50)
Virginia (26)
Washington D.C. (18)
Washington State (208)
West Virginia (1)
Wisconsin (15)
213,440 Results for "16".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bankruptcy
16 Years And 3 Texas Two-Steps Later, J&J’s Talc Lawsuit Awaits Key Ruling
Johnson & Johnson has been fighting thousands of lawsuits over its now-discontinued talc products for 16 years. A pending judge’s ruling could finally put the issue to bed once and for all.
March 12, 2025
·
4 min read
·
Annalee Armstrong
Venture capitalists
Lilly Partners With a16z on $500M VC Fund for Early-Stage Biotechs
The Biotech Ecosystem Venture Fund will combine the sourcing capabilities of venture capital firm Andreessen Horowitz (a16z) with Eli Lilly’s expertise in R&D—plus half a billion in capital from the Big Pharma.
January 10, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Iridex to Host Strategic Vision Call on April 16, 2025
April 10, 2025
·
1 min read
Press Releases
Protagonist Therapeutics Reports Granting of Inducement Award - April 16, 2025
April 17, 2025
·
2 min read
Press Releases
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 16, 2025
April 17, 2025
·
2 min read
Press Releases
Hubble Therapeutics closes Series A Financing to develop gene therapy cure for LCA16
March 26, 2025
·
4 min read
Press Releases
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - April 16, 2025
April 17, 2025
·
2 min read
Layoffs
ImmunityBio to Lay Off 16, Will Likely Need Additional Capital
ImmunityBio will lay off 16 employees in California and said it expects to need more funding to commercialize Anktiva, approved in April for non-muscle invasive bladder cancer.
September 4, 2024
·
2 min read
·
Angela Gabriel
Press Releases
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - April 16, 2025
April 17, 2025
·
1 min read
Earnings
Catalent Misses Fiscal Q1 Revenue Expectations as Pressure Mounts on Novo Holdings’ $16.5B Buyout
The contract manufacturer fell short of Wall Street’s projections for its first quarter of fiscal 2025, which ended Sept. 30, 2024. The miss comes amid growing opposition to Novo Holdings’ proposed $16.5 billion acquisition of Catalent.
November 6, 2024
·
3 min read
·
Tristan Manalac
1 of 21,344
Next
